Cargando…

Routes to Diagnosis for Suspected Sarcoma: The Impact of Symptoms and Clinical Findings on the Diagnostic Process

Background and Objectives. Sarcoma patients often experience delay before diagnosis. We examined the association between presenting symptoms/signs and time intervals for suspected sarcoma patients. Methods. 545 consecutive patients suspected for sarcoma referred over a one-year period were included....

Descripción completa

Detalles Bibliográficos
Autores principales: Buvarp Dyrop, Heidi, Vedsted, Peter, Rædkjær, Mathias, Safwat, Akmal, Keller, Johnny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220485/
https://www.ncbi.nlm.nih.gov/pubmed/28115911
http://dx.doi.org/10.1155/2016/8639272
_version_ 1782492638216192000
author Buvarp Dyrop, Heidi
Vedsted, Peter
Rædkjær, Mathias
Safwat, Akmal
Keller, Johnny
author_facet Buvarp Dyrop, Heidi
Vedsted, Peter
Rædkjær, Mathias
Safwat, Akmal
Keller, Johnny
author_sort Buvarp Dyrop, Heidi
collection PubMed
description Background and Objectives. Sarcoma patients often experience delay before diagnosis. We examined the association between presenting symptoms/signs and time intervals for suspected sarcoma patients. Methods. 545 consecutive patients suspected for sarcoma referred over a one-year period were included. Median time intervals in routes to diagnosis were collected from medical records and questionnaires. Results. 102 patients (18.7%) had a sarcoma; 68 (12.5%) had other malignancies. Median interval for the patient (time from first symptom to first doctor visit), primary care, local hospital, sarcoma center, diagnostic, and total interval for sarcoma patients were 77, 17, 29, 17, 65, and 176 days, respectively. Sarcoma patients visited more hospital departments and had longer median primary care (+10 days) and diagnostic intervals (+19 days) than patients with benign conditions. Median primary care (−19 days) and sarcoma center (−4 days) intervals were shorter for patients with a lump versus no lump. Median patient (+40 days), primary care (+12 days), diagnostic (+17 days), and total intervals (+78 days) were longer for patients presenting with pain versus no pain. GP suspicion of malignancy shortened local hospital (−20 days) and total intervals (−104 days). Conclusions. The main part of delay could be attributed to the patient and local hospitals. Length of time intervals was associated with presenting symptoms/signs and GP suspicion.
format Online
Article
Text
id pubmed-5220485
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-52204852017-01-23 Routes to Diagnosis for Suspected Sarcoma: The Impact of Symptoms and Clinical Findings on the Diagnostic Process Buvarp Dyrop, Heidi Vedsted, Peter Rædkjær, Mathias Safwat, Akmal Keller, Johnny Sarcoma Research Article Background and Objectives. Sarcoma patients often experience delay before diagnosis. We examined the association between presenting symptoms/signs and time intervals for suspected sarcoma patients. Methods. 545 consecutive patients suspected for sarcoma referred over a one-year period were included. Median time intervals in routes to diagnosis were collected from medical records and questionnaires. Results. 102 patients (18.7%) had a sarcoma; 68 (12.5%) had other malignancies. Median interval for the patient (time from first symptom to first doctor visit), primary care, local hospital, sarcoma center, diagnostic, and total interval for sarcoma patients were 77, 17, 29, 17, 65, and 176 days, respectively. Sarcoma patients visited more hospital departments and had longer median primary care (+10 days) and diagnostic intervals (+19 days) than patients with benign conditions. Median primary care (−19 days) and sarcoma center (−4 days) intervals were shorter for patients with a lump versus no lump. Median patient (+40 days), primary care (+12 days), diagnostic (+17 days), and total intervals (+78 days) were longer for patients presenting with pain versus no pain. GP suspicion of malignancy shortened local hospital (−20 days) and total intervals (−104 days). Conclusions. The main part of delay could be attributed to the patient and local hospitals. Length of time intervals was associated with presenting symptoms/signs and GP suspicion. Hindawi Publishing Corporation 2016 2016-12-26 /pmc/articles/PMC5220485/ /pubmed/28115911 http://dx.doi.org/10.1155/2016/8639272 Text en Copyright © 2016 Heidi Buvarp Dyrop et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Buvarp Dyrop, Heidi
Vedsted, Peter
Rædkjær, Mathias
Safwat, Akmal
Keller, Johnny
Routes to Diagnosis for Suspected Sarcoma: The Impact of Symptoms and Clinical Findings on the Diagnostic Process
title Routes to Diagnosis for Suspected Sarcoma: The Impact of Symptoms and Clinical Findings on the Diagnostic Process
title_full Routes to Diagnosis for Suspected Sarcoma: The Impact of Symptoms and Clinical Findings on the Diagnostic Process
title_fullStr Routes to Diagnosis for Suspected Sarcoma: The Impact of Symptoms and Clinical Findings on the Diagnostic Process
title_full_unstemmed Routes to Diagnosis for Suspected Sarcoma: The Impact of Symptoms and Clinical Findings on the Diagnostic Process
title_short Routes to Diagnosis for Suspected Sarcoma: The Impact of Symptoms and Clinical Findings on the Diagnostic Process
title_sort routes to diagnosis for suspected sarcoma: the impact of symptoms and clinical findings on the diagnostic process
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220485/
https://www.ncbi.nlm.nih.gov/pubmed/28115911
http://dx.doi.org/10.1155/2016/8639272
work_keys_str_mv AT buvarpdyropheidi routestodiagnosisforsuspectedsarcomatheimpactofsymptomsandclinicalfindingsonthediagnosticprocess
AT vedstedpeter routestodiagnosisforsuspectedsarcomatheimpactofsymptomsandclinicalfindingsonthediagnosticprocess
AT rædkjærmathias routestodiagnosisforsuspectedsarcomatheimpactofsymptomsandclinicalfindingsonthediagnosticprocess
AT safwatakmal routestodiagnosisforsuspectedsarcomatheimpactofsymptomsandclinicalfindingsonthediagnosticprocess
AT kellerjohnny routestodiagnosisforsuspectedsarcomatheimpactofsymptomsandclinicalfindingsonthediagnosticprocess